The world’s first flash glucose monitoring system, which requires only a scan rather than a traditional finger prick to test blood glucose, is now available in South Africa through the Centre for Diabetes and Endocrinology (CDE).
The ability to get a glucose reading with a quick, painless scan has ushered in a new era of bloodless, simple and calibration-free visualisation of glycaemic control.
The unique technology replaces blood glucose meters, while giving patients many of the benefits of continuous glucose monitoring (CGM), including real-time glucose values, trend information and comprehensive reports.
This new system includes a flexible filament sensor, which is inserted 5mm under the skin. The filament is connected to a small, round disc and held in place on the skin with medical adhesive. The sensor remains inserted for 14 days. One hour after application to the upper arm, it begins reading blood glucose levels and continues to do so for up to 14 days.
The hi-tech monitor, first introduced in Europe, has provided unparalleled levels of data necessary in the management of diabetes and has revolutionised the way people with Type I diabetes can manage their glucose levels.
“When the technology was first introduced in Europe a voluntary pilot project was initiated. More than 50,000 people participated in the pilot between 2014 and 2016 yielding 409 million data points. The analysed data provided invaluable insights into glucose monitoring,” said Executive Chairman of CDE, Dr Larry Distiller.
“The new flash technology allows users to scan and check their blood glucose at any time without any limit. Practically, pilot project participants scanned on average up to 16 times per day. Research found that those who scanned the most had the best control of their blood glucose,” continued Dr Distiller.
In addition to being always available and providing immediate personal monitoring, the reader data can be downloaded and analysed using specific software. This produces detailed and informative visual outputs on daily glycaemic trends and variability and highlights statistical risks of hypoglycaemia and hyperglycaemia according to time of day. In time, patients will also be able to scan the sensor using their cell phone.
“This new technology is approved for dosing insulin, except in three cases when a finger stick is recommended: when hypoglycaemic, when glucose is changing rapidly, or when symptoms don’t match the system’s readings,” concluded Distiller.